학술논문
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USA
Document Type
Article
Author
Source
In: Advances in Therapy . (Advances in Therapy, June 2023, 40(6):2784-2800)
Subject
Language
English
ISSN
18658652
0741238X
0741238X